Cargando…
Deficiency of C-reactive protein or human C-reactive protein transgenic treatment aggravates influenza A infection in mice
C-reactive protein (CRP) has been shown to be a potential candidate target in the immunotherapy of severe influenza A infection. However, it is unclear on the pathogenesis associated with CRP in influenza infections. Here, we used influenza A H1N1 CA04 to infect human CRP transgenic mice (KI), CRP k...
Autores principales: | Zhang, Zhuohan, Gao, Yongjun, Li, Li, Luo, Junhao, Gao, Rongbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584053/ https://www.ncbi.nlm.nih.gov/pubmed/36275680 http://dx.doi.org/10.3389/fimmu.2022.1028458 |
Ejemplares similares
-
A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19
por: Luo, Junhao, et al.
Publicado: (2023) -
C-reactive protein deficiency ameliorates experimental abdominal aortic aneurysms
por: Fu, Yu, et al.
Publicado: (2023) -
Evolution of C-Reactive Protein
por: Pathak, Asmita, et al.
Publicado: (2019) -
C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases
por: Gao, Rongbao, et al.
Publicado: (2017) -
C-Reactive Protein in Atherothrombosis and Angiogenesis
por: Badimon, Lina, et al.
Publicado: (2018)